Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12605000735651
ACTRN12605000735651
Completed
Not Applicable

The BNP Assisted Teatment to Lessen Serial Cardiac Readmissions and Death.

Health Research Council of New Zealand0 sites363 target enrollmentNovember 11, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHeart FailureCardiovascular - Other cardiovascular diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
Health Research Council of New Zealand
Enrollment
363
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 11, 2005
End Date
October 31, 2020
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Symptomatic congestive HF as defined by Framingham criteria (Table 1\), requiring admission to hospital in subjects able to give competent informed consent.

Exclusion Criteria

  • •Active myocarditis/pericarditis.Under active consideration for cardiac transplantation. Life expectancy due to non\-cardiovascular disease \<24 months.Severe hepatic or pulmonary disease (FEV1 \<1L).Renal impairment with creatinine at discharge from index admission \>0\.25mmol/L.Transient HF in association with myocardial infarction treated with acute revascularisation and subsequent ejection fraction during index admission \>40%.Severe valvular disease being considered for surgery, or severe aortic stenosis (valve area \<1cm2\), or symptoms of HF secondary to mitral stenosis.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
T-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease a prospective randomized trial<br>diabetes cardiac diseasediabetes mellitus10012653
NL-OMON47526Medical university of Vienna200
Active, not recruiting
Phase 1
Prevention of heart disorders in diabetic patients on the basis of NT-proBNP values.
EUCTR2015-000239-34-NLMedizinische Universität Wien2,400
Active, not recruiting
Phase 1
Prevention of heart disorders in diabetic patients on the basis of NT-proBNP values.
EUCTR2015-000239-34-ATMedizinische Universität Wien2,400
Active, not recruiting
Phase 1
Prevention of heart disorders in diabetic patients on the basis of NT-proBNP values.
EUCTR2015-000239-34-ESMedizinische Universität Wien2,400
Active, not recruiting
Phase 1
A clinical study to investigate the use of commonly used heart failure medicines in the prevention of heart related illnesses in patients with diabetes mellitus but without heart disease.
EUCTR2015-000239-34-GBMedical University of Vienna2,400